Cover Image

Phake the deadly world of falsified and substandard medicines /

Main Author:	Bate, Roger,
Format:	Book
Language:	English
Published:	Washington, D.C. : AEI Press, [2014]
Physical Description:	xxvi, 457 pages : illustrations ; 24 cm.
Subjects:	Pharmaceutical industry -- Corrupt practices. Drug adulteration. Product counterfeiting. Drug traffic.

Similar Items

Selling sickness : how the world's biggest pharmaceutical companies are turning us all into patients
by: Moynihan, Ray.
Published: (2005)

Prescriptions for death : the drugging of the Third World
by: Silverman, Milton, 1910-1997.
Published: (1982)

A healthy business? : world health and the pharmaceutical industry
by: Chetley, Andrew.
Published: (1990)

China Rx : exposing the risks of America's dependence on China for medicine
by: Gibson, Rosemary, 1956-
Published: (2018)

The International supply of medicines : implications of U.S. regulatory reform
Published: (1980)

Securing the pharmaceutical supply chain : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session, on examining securing the pharmaceutical supply chain, focusing on how the Food and Drug Administration faces challenges overseeing the foreign drug manufacturing supply chain, September 14, 2011
by: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions,
Published: (2014)

Counterfeit drugs : fighting illegal supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 27, 2014
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations,
Published: (2015)

Counterfeit prescription pills containing fentanyls : a global threat
Published: (2016)

Sick crime : counterfeit drugs in the United States : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, November 1, 2005
by: United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
Published: (2006)

An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to Human Drug Compounding and Drug Supply Chain Security, and for Other Purposes
by: United States,
Published: (2013)

Pharmaceutical supply chain security
by: Thaul, Susan,
Published: (2019)

Dangerous doses : how counterfeiters are contaminating America's drug supply
by: Eban, Katherine.
Published: (2005)

To Catch a Fake : Wide World of Counterfeits
Published: (2014)

Bottle of lies : the inside story of the generic drug boom
by: Eban, Katherine,
Published: (2019)

Counterfeit bulk drugs : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000
by: United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations,
Published: (2000)

The opioid crisis and the Dark Web : how transnational criminals devastate U.S. communities : March 28, 2018, briefing of the Commission on Security and Cooperation in Europe
by: United States. Congress. Commission on Security and Cooperation in Europe,
Published: (2018)

Pharmaceutical supply chain security : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, July 11, 2006
by: United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
Published: (2007)

Reforming the drug compounding regulatory framework : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Published: (2014)

Counterfeit controlled prescription drug availability in Pennsylvania and Delaware
Published: (2020)

Dangerous medicine : the risk to American consumers from prescription drug diversion and counterfeiting : report by the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, U.S. House of Representatives
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Published: (1986)

Buyer beware : the danger of purchasing pharmaceuticals over the Internet : hearings before the Permanent Subcommittee on Investigations of the Committee on Governmental Affairs, United States Senate, One Hundred Eighth Congress, second session, June 17 and July 22, 2004
by: United States. Congress. Senate. Committee on Governmental Affairs. Permanent Subcommittee on Investigations.
Published: (2004)

To Catch a Fake : Fake Credentials
Published: (2014)

FDA Counterfeit Drug Task Force interim report safe & secure
by: FDA Counterfeit Drug Task Force (U.S.)
Published: (2003)

Fentanyl, Inc. : how rogue chemists are creating the deadliest wave of the opioid epidemic
by: Westhoff, Ben,
Published: (2019)

Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies
Published: (2014)

Buyer beware : public health concerns of counterfeit medicine : hearing before the Special Committee on Aging, United States Senate, one hundred seventh Congress, second session, Washington, DC, July 9, 2002
by: United States. Congress. Senate. Special Committee on Aging.
Published: (2002)

Design and manufacture of pharmaceutical tablets
by: Eyjolfsson, Reynir,
Published: (2015)

Prescription drug diversion and counterfeiting : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first-[second] session
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Published: (1986)

Pathway to global product safety and quality : a special report
Published: (2011)

State programs and services in food and drug control
by: Raynes, Paul M.
Published: (1990)

Drug pricing investigation: AbbVie : Humira and Imbruvica : staff report
by: United States. Congress. House. Committee on Oversight and Reform,
Published: (2021)

Practical pharmaceutics : an international guideline for the preparation, care and use of medicinal products
Published: (2015)

Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations,
Published: (2001)

Guidance for industry possible dioxin/PCB contamination of drug and biological products
Published: (1999)

Guidance for industry residual solvents in drug products marketed in the United States
Published: (2009)

Pharmaco-imaging in drug and biologics development : fundamentals and applications
Published: (2014)

Prelinger Archives The Relaxed Wife
Published: (1957)

Guidance for industry Q3C tables and list
Published: (2003)

Sterile product development : formulation, process, quality and regulatory considerations
Published: (2013)

How to integrate quality by efficient design (QbED) in product development
by: Mittal, Bhavishya,
Published: (2020)